First Graphene (ASX: FGR) targets aerospace prepregs as Aeropreg deal tests PureGRAPH commercial scale

First Graphene Limited (ASX: FGR) has entered a three-year development and commercialisation agreement with Turkish composites manufacturer Aeropreg, creating a route to test whether years of graphene-enhanced carbon fibre development can progress into repeatable commercial production. The companies will combine First Graphene’s PureGRAPH material and proprietary epoxy concentrates with Aeropreg’s existing prepreg manufacturing and resin-development capabilities, initially focusing on controlled graphene loading, mechanical performance and manufacturability. If the development programme meets its technical targets, the companies intend to progress the material toward commercial launch through Aeropreg’s existing customer channels across aerospace, automotive, marine and sporting-goods markets. The agreement therefore gives First Graphene a potentially important manufacturing bridge between laboratory-scale materials performance and customer-ready composite products, although no minimum purchase volumes, contract revenue or commercial launch date have been disclosed.

The commercial distinction is important for First Graphene. The Perth-based advanced materials company already operates graphene production capacity and has spent years demonstrating potential applications across cement, composites, mining materials and other industrial products, but its financial results remain those of a company still converting technical development into meaningful recurring revenue. Aeropreg gives First Graphene access to an established prepreg manufacturing process, in-house resin development and testing capabilities, while its parent group has recently secured approved-supplier status with Turkish Aerospace. That combination could shorten the path toward demanding aerospace and defence applications, but successful validation remains a prerequisite rather than an assured commercial outcome.

Why does the Aeropreg agreement matter more than another graphene laboratory trial for First Graphene?

The central challenge for advanced materials companies is rarely proving that a material can produce an improvement under controlled conditions. The harder task is demonstrating that those improvements remain consistent when production moves into industrial equipment, raw-material batches vary and customers require repeatable specifications at commercial volumes.

The Aeropreg programme moves First Graphene closer to that test. Its PureGRAPH material will need to be incorporated consistently into the resin systems used to impregnate carbon fibres, with the development process focused on controlled graphene loading before the companies evaluate strength, durability, performance and manufacturing repeatability.

Prepreg manufacturing requires greater consistency than simply mixing an additive into a resin and producing a one-off laboratory coupon. Resin distribution, fibre wet-out, curing behaviour and graphene dispersion must remain stable enough for manufacturers to produce material repeatedly while downstream customers receive predictable mechanical properties.

Aeropreg adds an industrial setting in which those variables can be tested. The Turkish company develops its own resin systems and performs chemical, physical, thermal and mechanical testing internally, meaning formulation changes can be evaluated alongside the manufacturing process rather than being developed separately and then handed to an outside producer.

For First Graphene, successful validation could create a more scalable route to market than conducting individual development programmes with every potential end customer. A standardized graphene-enhanced prepreg that an established manufacturer can supply through existing sales channels potentially moves PureGRAPH closer to becoming an ingredient inside a repeatable commercial product.

How could PureGRAPH change the performance economics of carbon fibre prepregs?

Carbon fibre composites are already valued because they combine high strength and stiffness with substantially lower weight than many conventional materials. Their use spans aircraft structures, performance vehicles, marine components, sporting equipment and a growing range of industrial applications where strength-to-weight performance justifies higher material costs.

Graphene additives offer another potential performance lever. Properly dispersed graphene can influence mechanical, thermal, electrical and barrier properties within polymer systems, although the actual improvement depends heavily on formulation, loading level, dispersion and manufacturing conditions. More graphene is not automatically better because excessive loading can increase viscosity, complicate processing or cause agglomeration that undermines material performance.

That makes First Graphene’s epoxy concentrate technology strategically relevant. The company is not simply supplying dry graphene powder and asking Aeropreg to determine how to disperse it. The programme incorporates proprietary concentrates intended to make PureGRAPH easier to introduce consistently into epoxy systems.

If the combined material delivers higher mechanical performance without requiring major changes to Aeropreg’s existing production process, customers could potentially improve component performance, reduce weight or redesign structures using the enhanced material. Those outcomes remain dependent on validation, however, and the companies have not yet disclosed quantified strength improvements, weight reductions, cost-per-component savings or other commercial performance targets for the new product.

The most valuable result would therefore be a formulation that offers sufficient additional performance to justify its cost while remaining compatible with existing composite manufacturing processes. A technically impressive material that requires expensive production changes would have a narrower commercial opportunity than one that can enter established prepreg and component-manufacturing workflows.

Why could Aeropreg’s aerospace credentials shorten the route into higher-value applications?

Aeropreg manufactures carbon, glass, aramid and basalt fibre prepregs for sectors including aviation, automotive, marine, medical, wind energy and sporting goods. Its prepreg production operates under AS9100 aerospace quality management certification, placing its manufacturing system within a quality framework widely used across aviation, space and defence supply chains.

The relationship became more strategically relevant in June 2026 when Aeropreg parent Spinteks was added to the Turkish Aerospace approved supplier list for composite manufacturing. Aeropreg carries out prepreg manufacturing within the group, giving the business a direct connection to an aerospace supply environment where material qualification standards are significantly more demanding than many general industrial applications.

Approved-supplier status does not mean a graphene-enhanced First Graphene product has already been qualified for Turkish Aerospace programmes. Any individual material would still need to satisfy relevant customer, application and certification requirements before being incorporated into aircraft or defence structures.

It does, however, give First Graphene a partner that understands the qualification processes, production documentation and testing discipline associated with aerospace-grade materials. That could be more valuable than working with a general composites producer unfamiliar with the requirements of high-consequence structural applications.

The aerospace opportunity is also commercially attractive because modern aircraft use substantial quantities of carbon fibre reinforced materials in primary and secondary structures. Qualification cycles can be long, but successful material adoption can create durable programmes because aerospace manufacturers generally avoid frequent changes to validated materials once production is established.

How does the Aeropreg deal connect with First Graphene’s acquisition of MITO Materials in the United States?

The Aeropreg agreement follows First Graphene’s June acquisition of the assets, intellectual property, product lines and manufacturing capabilities of United States-based MITO Material Solutions. That transaction expanded the company into functionalised graphene additives and brought additional relationships across composites markets, including customers progressing through later-stage testing.

The two initiatives are complementary rather than interchangeable. MITO strengthened First Graphene’s presence and technology portfolio in North America, particularly around composite additives, while Aeropreg provides a European and Turkish manufacturing route for prepreg products that could eventually serve aerospace, defence, automotive and other industries.

Together they suggest First Graphene is trying to shift its composites strategy away from selling graphene as an isolated raw material and toward supplying formulated technologies that solve specific manufacturing problems. That can improve commercial positioning because composite manufacturers generally care less about purchasing graphene itself than about whether an additive can improve a finished component without disrupting their production process.

The broader product portfolio may also allow First Graphene to approach different resin systems and end markets with more tailored formulations. MITO’s functionalised graphene technologies and PureGRAPH do not necessarily serve identical applications, giving the company potentially more ways to match graphene chemistry with specific customer requirements.

The strategic opportunity is significant, but integration and commercialization remain the real tests. Acquiring additional technology expands First Graphene’s capabilities, while agreements such as Aeropreg provide pathways to production. Shareholder value ultimately depends on those capabilities translating into repeat orders and materially higher revenue.

What do First Graphene’s latest financial results reveal about the urgency of commercialisation?

First Graphene’s financial results make revenue conversion particularly important. The company reported revenue from customer contracts of A$537,594 for the year ended June 30, 2026, up 14.8% from A$468,397 in the previous year. Gross profit more than doubled to A$220,562 as cost of goods sold declined despite higher revenue, producing a gross margin of about 41%, compared with roughly 22% a year earlier.

Those improvements are encouraging at the product level, but the absolute revenue base remains small relative to the company’s operating costs. First Graphene recorded a full-year loss of approximately A$5.40 million, broadly similar to the prior year, while operating cash outflow improved to A$2.39 million from A$2.72 million.

Cash and cash equivalents stood at A$2.87 million at June 30, compared with A$2.61 million a year earlier. The balance was supported by financing activity, including A$3.5 million from share issuance during the financial year.

The company’s audited accounts state that its ability to continue as a going concern depends on securing additional funding through equity placements to finance operational and marketing activities. The auditor identified a material uncertainty relating to going concern while leaving its audit opinion unmodified.

That financial position gives the Aeropreg agreement greater significance than it might have for a much larger materials group. First Graphene does not simply need additional technical validation. It needs development programmes to move progressively toward purchase orders, recurring volumes and a revenue base capable of supporting its commercial and research infrastructure.

What does First Graphene’s share price suggest before the Aeropreg announcement reaches ASX trading?

First Graphene shares last closed at A$0.055 on October 2, before the Aeropreg announcement was released. The stock was unchanged from its October 1 close and had traded largely around the A$0.05 to A$0.06 range through much of September.

The company’s market capitalisation was approximately A$48.8 million at the latest close. That valuation remains many times larger than its current annual revenue base, indicating that the share price incorporates expectations around future commercialization rather than being supported primarily by existing sales.

First Graphene had approximately 887 million shares outstanding at the latest available market-data point, with the share count having increased materially over the previous year. That matters because a development-stage business that continues funding operations through equity needs commercial progress to outpace the impact of additional capital issuance over time.

There is no valid post-announcement market reaction yet because the Aeropreg development was released after the most recent ASX session. Any subsequent price movement should therefore be separated from the trading that preceded the agreement.

The more meaningful valuation catalyst would be evidence that Aeropreg moves from development to commercial manufacturing, particularly if that transition includes customer qualification, contracted volumes or recurring PureGRAPH consumption.

What needs to happen before graphene-enhanced prepreg becomes a real commercial product?

The first requirement is manufacturing repeatability. First Graphene and Aeropreg need to demonstrate that PureGRAPH can be incorporated at controlled loading levels across prepreg production without creating unacceptable variation from batch to batch.

Mechanical validation follows. Strength, durability and other relevant performance characteristics need to be demonstrated against the requirements of targeted applications. Improvements will need to be large and repeatable enough to justify the additional material and qualification costs associated with using graphene.

Manufacturability is equally important. A material can produce excellent laboratory test results and still struggle commercially if resin viscosity, curing behaviour, storage requirements or downstream processing make it difficult for customers to adopt.

Once those stages are completed, qualification becomes increasingly customer-specific. Sporting goods and some industrial applications can generally reach the market more quickly than aerospace structural materials, where qualification and certification processes can extend over lengthy periods.

That creates a potentially useful commercialization sequence. Aeropreg has sales channels spanning several industries, giving the partners the option of pursuing applications with different qualification thresholds rather than relying entirely on aerospace adoption from the outset.

The agreement runs for three years, providing time to progress through those stages, but it does not guarantee a product launch at the end of that period. First Graphene has explicitly made commercialization subject to successful trial results, preserving an important distinction between an agreed development programme and contracted future sales.

Could Aeropreg become the commercial bridge First Graphene needs for its 100-tonne graphene capacity?

First Graphene operates a graphene manufacturing facility in Henderson, Western Australia with stated annual capacity of approximately 100 tonnes. The strategic challenge has never been simply creating more production capability; it has been developing end markets capable of consuming graphene at meaningful volumes.

Carbon fibre composites could contribute to that objective because prepreg manufacturing can potentially embed graphene into standardized materials sold repeatedly into multiple end-use sectors. If Aeropreg establishes one or more successful formulations, demand for PureGRAPH could become tied to production volumes rather than individual development experiments.

How much graphene such a product could consume remains unknown. The companies have not disclosed expected loading rates, annual prepreg production volumes, minimum purchase commitments or sales forecasts. It would therefore be premature to describe the agreement as materially utilizing First Graphene’s existing production capacity.

The opportunity is better viewed as establishing a scalable commercial mechanism. First Graphene supplies the graphene technology, Aeropreg formulates and manufactures the prepreg, and Aeropreg’s customer channels provide a route into end applications. That structure can potentially be repeated across customers without First Graphene becoming a carbon fibre prepreg manufacturer itself.

The next evidence should come from technical milestones rather than another broad market estimate. Successful repeatable loading, validated performance, customer qualification and the first commercial order would each progressively reduce the gap between First Graphene’s existing manufacturing capacity and actual graphene demand.

What are the key takeaways from First Graphene’s three-year Aeropreg agreement?

• First Graphene Limited has entered a three-year development and commercialisation agreement with Turkish prepreg manufacturer Aeropreg.
• The companies will develop a carbon fibre prepreg incorporating First Graphene’s PureGRAPH material and proprietary epoxy concentrates.
• Initial work will focus on repeatable graphene loading, strength, durability, performance and industrial manufacturability.
• Commercial launch remains conditional on successful development and trial results.
• Aeropreg manufactures prepregs for aerospace, automotive, marine, sporting goods and other markets and has internal resin-development and testing capabilities.
• Aeropreg operates under AS9100 aerospace quality management certification, while parent company Spinteks joined the Turkish Aerospace approved supplier list in June 2026.
• The partnership complements First Graphene’s recent acquisition of United States composites technology business MITO Material Solutions.
• First Graphene reported FY2026 customer revenue of A$537,594, up 14.8%, but remained loss-making with a net loss of approximately A$5.40 million.
• Cash stood at A$2.87 million at June 30, while the audited accounts identified continued dependence on additional funding as part of the going-concern assessment.
• First Graphene shares last closed at A$0.055 before the announcement, giving the company a market capitalisation of approximately A$48.8 million.
• No minimum PureGRAPH volumes, commercial revenue, launch date or financial value have been disclosed for the Aeropreg agreement.
• The strongest future proof points will be successful manufacturing validation, customer qualification and the first recurring commercial orders.